In this age of coronavirus, with vaccine experimentation moving at historic pace to the clinical trials phase, the ideal inoculation policy would emphasize age more than work-exposure risk, according to a study involving Washington University in St. Louis economists.
It is not easy to conduct human milk research during a pandemic. Yet despite the consistent lack of quality evidence for transmission of viral RNA from breast milk, some leaders are pushing ahead by altering public health and clinical practice guidance, according to E.A. Quinn, associate professor of biological anthropology in Arts & Sciences at Washington University in St. Louis.
Rob Morgan, in Arts & Sciences, shares the story of how he steered the Beyond Boundaries Program — in its first cohort in 2019-2020 — to roll with the challenges of COVID-19. Embracing resiliency and creativity, Morgan and the program pivoted, creating a podcast to bridge the digital divide.
COVID-19 caught public health systems in the U.S. unprepared to detect, track and contain the virus. The pandemic has exposed a multitude of deficiencies that require a wholesale reinvention of the field of public health, said four leading experts in a recently published essay.
This fall, each and every member of the Washington University community who will be on campus will be required to follow four steps — four public health measures that must be completed by students, faculty and staff individually, but will have an impact globally.
Researchers at Washington University School of Medicine in St. Louis have created a COVID-19 vaccine candidate from a replicating virus. This experimental vaccine has proven effective at preventing pneumonia in mice.
Up to 5,000 St. Louis County residents will be invited to participate in a survey and testing regarding COVID-19 to help gauge the impact the coronavirus has had on the county’s residents. Washington University in St. Louis and the St. Louis County Department of Public Health are leading the project.
New research from Washington University School of Medicine suggests that the immune systems of seriously ill COVID-19 patients can’t do enough to protect them from the virus. The researchers propose that boosting the activity of immune cells may be a good treatment strategy for COVID-19.
Since spring, Washington University has been planning for the upcoming fall semester to determine how to bring students, faculty and staff back to the Danforth Campus as safely as possible as the COVID-19 pandemic continues to evolve in the St. Louis region, across the country and around the world. Today the university announced its plans for the start of the next academic year, which begins in August and September.
To help efforts to find drugs and vaccines for COVID-19, researchers at Washington University School of Medicine developed a hybrid virus that will enable more scientists to enter the fight against the pandemic. The researchers genetically modified a mild virus.